NASA

motion sickness

FDA rejects Defender's motion sickness nasal gel candidate

A nasal gel version of the motion sickness drug scopolamine, developed by Defender Pharmaceuticals, has failed to make the grade with the FDA.

Kevin Dunleavy Jan 30, 2024 5:00pm

ISS International Space Station space NASA

Lilly teams with Redwire on orbital drug development experiments

Oct 30, 2023 2:39pm

space station spacewalk

SpaceX sends drug delivery implants to space station for study

Aug 31, 2021 7:15am